Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium

ABSTRACT The use of a liquid biopsy to assess molecular residual disease (MRD) of solid tumors holds significant promise for improving outcomes for patients with cancer. Liquid biopsies are a minimally invasive approach for the identification of circulating tumor biomarkers through a simple blood sa...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Andrew G. Hadd, Angela Silvestro, Brittany Avin McKelvey, Jonathan Baden, Christina Bormann Chung, Ben Brown, Fernando Cruz‐Guilloty, James Godsey, Gregory Jones, Cheng‐Ho Jimmy Lin, Dorys Lopez Ramos, Daniel Norton, Melanie R. Palomares, Carol Pena, Thereasa Rich, Angel Rodriguez, Mark Stewart, Diana Merino Vega, Lauren C. Leiman
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2025-03-01
Serie:	Clinical and Translational Science
Soggetti:	ctDNA liquid biopsy MRD
Accesso online:	https://doi.org/10.1111/cts.70185
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!